A placebo-controlled, parallel group multicenter phase III trial of Topically-applied Glyceryl Trinitrate (GTN) for the Treatment of Erectile Dysfunction (ED)

Trial Profile

A placebo-controlled, parallel group multicenter phase III trial of Topically-applied Glyceryl Trinitrate (GTN) for the Treatment of Erectile Dysfunction (ED)

Planning
Phase of Trial: Phase III

Latest Information Update: 26 Apr 2018

At a glance

  • Drugs Nitroglycerin (Primary)
  • Indications Erectile dysfunction
  • Focus Registrational; Therapeutic Use
  • Sponsors Futura Medical
  • Most Recent Events

    • 26 Apr 2018 According to a Futura Medical media release, the company expects to dose last patient by end of June 2019 and to report efficacy results by December 2019.
    • 26 Apr 2018 According to a Futura Medical media release, the company is targeting for first patient to be dosed by the end of September 2018.
    • 14 Mar 2018 According to a Futura Medical media release, first patient is expected to enroll early in Q32018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top